Market Research Engine has published a new report titled as “Global Genome Editing Market Analysis by Application, Technology and End User – Forecast 2015 to 2021”.
The global genome Editing market is expected to grow at a CAGR of more than 14.0% between 2015 and 2023. The global genome Editing market is estimated to cross US$ 7.0 billion by the end of 2023.
The global genome editing market is rapidly increasing due to the increased government funding for genomics technology, rise in the production of genetically modified crops and technological advancements these all factors are driving the growth of this market.
Recent developments across genome editing technologies have resulted in the creation of next generation nucleases that have higher levels of accuracy when correcting genetic mutations and defects. The classes under the genome editing technologies are the 4 broad families of nucleases: ZFNs, TALENs, CRISPR/Cas9, and Meganucleases.
Gene editing technologies have an impact across multiple applications areas including plant and animal genetic engineering. However, the area of most disruption is across human cell line engineering, which enables the development of next generation’s therapies and drugs. However, the agricultural industry has seen more success with gene editing techniques largely due to the less stringent regulatory environment.
Scope of the Report
This market research report categorizes the genome editing market into the following segments:
• Antisense Technology
• Other Technologies
• Cell Line Engineering
• Animal Genetic Engineering
• Plant Genetic Engineering
• Other Applications
By End User
• Biotechnology and Pharmaceutical Companies
• Government and Academic Research Institutes
• Other Research Organizations
By Geographical Region
- North America
• Rest of the World
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Genome Editing/Engineering Market, By Technology
7 Global Genome Editing/Genome Engineering Market, By Application
8 Global Genome Editing/Engineering Market, By End User
9 Genome Editing/Genome Engineering Market, By Region
10 Competitive Landscape
11 Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.2 Merck KGaA
11.3 Horizon Discovery Group PLC
11.4 Genscript USA Inc.
11.5 Sangamo Biosciences, Inc.
11.6 Integrated DNA Technologies, Inc.
11.7 Lonza Group Ltd.
11.8 New England Biolabs, Inc.
11.9 Origene Technologies, Inc.
11.10 Transposagen Biopharmaceuticals, Inc.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States